Global Tumor Ablation Market Insights, Forecast to 2025

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2015 is about 50.6%, and the proportion of Microwave Ablation in 2015 is about 21.7%.
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2015 is about 28.5%.
The global Tumor Ablation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tumor Ablation market based on company, product type, end user and key regions.

This report studies the global market size of Tumor Ablation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tumor Ablation in these regions.
This research report categorizes the global Tumor Ablation market by top players/brands, region, type and end user. This report also studies the global Tumor Ablation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Angiodynamics
Medtronic
Boston Scientific
Galil Medical
Neuwave Medical
Misonix
Merit Medical
Sonacare Medical
EDAP TMS

Market size by Product
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Market size by End User
Liver Cancer
Lung Cancer
Kidney Cancer
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tumor Ablation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tumor Ablation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tumor Ablation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tumor Ablation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Tumor Ablation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tumor Ablation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions